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Abstract
Published histological studies of the hilar plate or entire biliary remnant at the time of Kasai 
portoenterostomy (KHPE) have not provided deep insight into the pathogenesis of biliary atresia, 
relation to age at surgery, prognosis or the basis for successful drainage. We report the detailed 
histological findings in 172 centrally reviewed biliary remnants with an average of six sections per 
subject. The predominant active lesion consisted of active fibroplasia with or without a 
mononuclear cell infiltrate concentric to ducts or peribiliary glands. Necroinflammatory lesions 
were rare and clustered in a few subjects. Histological heterogeneity of lesions was common 
within a given remnant. However, histologic patterns were homogeneously inactive or active in 
most subjects; homogeneity did not correlate with age at KHPE, presence/absence of congenital 
anomalies at laparotomy indicative of heterotaxy, and outcome. Remnants from the youngest 
subjects were more likely than older subjects to be homogeneously inactive suggesting 
significantly earlier onset in the youngest subset. Conversely remnants from the oldest subjects 
were often homogeneously active suggesting later onset or slower progression. More data is 
needed in remnants from subjects <30 days old at KHPE and in those with visceral anomalies. 
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Prevalence of partially preserved epithelium in active fibroplastic BA lesions at all ages suggests 
that epithelial regression or injury may not be a primary event or that re-epithelialization is already 
underway at the time of KHPE. We hypothesize that outcome after KHPE is the result of 
competition between active fibroplasia and re-epithelialization of retained, collapsed but not 
obliterated lumens. The driver of active fibroplasia is unknown.
Introduction
The etiology of biliary atresia remains an enigma. Multiple pathways and potential etiologic 
subsets have been proposed; the relative influence of environment and genetics continues to 
be debated (1, 2, 3). The histopathology of the biliary remnant in BA previously has 
attracted interest for potential prognostic value and as a source of insight into pathogenesis. 
Remnant histology has been described mainly in tissue from the most proximal portion of 
the hepatic ducts near the hilum (4–6). Forty-eight hilar remnants, of which 26 included the 
entire hepatic duct and gall bladder, were serially sectioned by Gautier who observed 
inflammation and fibrosis with variable retention of epithelial structures that he sorted into 
main ducts and peribiliary glands. Bland fibrotic remnants were mostly distal in these 
samples. Based on histopathology, Gautier speculated that BA is an ascending process that 
begins at or prior to birth and that destructive inflammation might be a secondary feature. In 
more extensively sampled remnants of the extrahepatic biliary tree, Tan et. al. observed that 
absent duct remnants and absent inflammation at the porta hepatis associated with poor 
prognosis but this study did not provide a detailed histopathological analysis of the entire 
remnants (7). Other reports suggest that histology of the fibrous plate may predict outcome 
(8–10), but there has been little agreement.
The success rate of the KHPE is approximately 50–60% and better outcome is generally 
related to younger age at surgery 11–13)). However, a survival benefit has yet to be 
established and may not exist in infants less than 30 days old at the time of operation (14). 
This subset may grow as methods for early detection improve (15, 16). Unfortunately, 
histologic study of biliary remnants has thus far provided little insight into conditions for 
success or failure of the KHPE, nor provided deeper understanding of etiopathogenesis of 
BA.
The CHildREN Network*, a consortium of 15 institutions in North America sponsored by 
the NIDDK has compiled clinical and pathological data on 500 subjects with biliary atresia 
accessioned between 2003 and 2015. The CHildRENS database includes centrally reviewed 
liver biopsies obtained at or near the time of the KHPE (17) and protocol-driven step-
sectioned biliary remnants in most subjects. We report here the detailed histological findings 
in biliary remnants from 172 subjects based on conformity to the submission protocol with 
an average of six sections per subject. We correlate findings with gender, age at KHPE, 
presence/absence of congenital anomalies at laparotomy indicative of heterotaxy, and 
outcome.
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Methods
Clinical data from PROBE* consisted of gender, age at KHPE, the major associated 
congenital anomalies known as biliary atresia-splenic malformation syndrome-heterotaxy 
syndrome (BASM), and other major anomalies (18).
Information collected at surgery consisted of intra-abdominal anatomic abnormalities, status 
of the common bile duct, findings on intra-operative cholangiogram and anatomic type (Ohi 
classification) of biliary atresia (19) Outcome was defined as normalization of total serum 
bilirubin at 3 months post KHPE or survival with the native liver at age 2 years post KHPE.
All biliary remnants were oriented by the surgeon (proximal to distal). Most were 
photographed at the time of gross examination. Step-sections perpendicular to the axis of the 
hepatic duct from the hilum to the proximal common duct were designated hepatic duct 
series B. A second series of axial cross sections extending from the cystic duct to the tip of 
the gall bladder were designated cystic duct/gall bladder series G (Figure 1). Identifiable 
common duct components were infrequently received and were included in continuity with 
the hepatic duct series.
Central evaluation and classification of one H&E stained section from each level was by 
consensus of 4 or more experienced pediatric pathologists using a protocol designed for 
remnant evaluation, ChildREN Network Form 10B. This protocol interrogates for each level 
as follows: inclusion of liver tissue in the section; classification of the lesion based on the 
appearance of the duct remnant as active or inactive based on character and amount of the 
inflammatory infiltrate and dominance of active fibrosis vs inactive mature scar; subtypes of 
inflammatory cells; number of residual lumens; character and amount of residual surface 
epithelium in residual main channels; presence of smooth muscle bundles; contiguous lymph 
nodes; ectopic cartilage; and number of contiguous compact nests of tertiary lymphoid 
tissue. Remnant data were entered into an Excel file at the Data Coordinating Center and 
analyzed by the senior author. Summary of results are displayed in bar graphs (Figure 2A–I) 
and in Tables 1–2.
Inflammation was assessed semi-quantitatively as present or absent at low magnification 
(4X) and further qualified as to predominance of either mononuclear or polymorphonuclear 
cells. The designation active was subclassified based upon presence of concentric necrosis/
exudate/granulation tissue (Figure 3), or cellular reactive fibroblastic tissue around residual 
lumens (Figure 4). Active concentric fibroplasia was designated mixed when a consensus 
was reached that the accompanying mononuclear cell inflammatory infiltrate exceeded 
minimal to absent (Figure 5).
Inactive lesions were defined by paucicellular dense fibrous scar tissue with little or no 
central inflammation. Inactive lesions included discrete dense fibrous cords and less well 
defined but recognizable localized scar tissue. Inflammation was usually absent; “minor” 
mononuclear infiltrates occasionally remained, though overshadowed by the extent or 
completeness of duct replacement by mature fibrous tissue (Figure 6). Occasionally inactive 
lesions contained tiny epithelial cell nests consistent with peribiliary glands with or without 
a larger tubular structure that may have been a stenotic residual lumen embedded in scar. 
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One-hundred-one levels included in the inactive category were judged to be well-oriented 
based on centrifugal/peripheral distribution of normal vascular structures and nerves along 
the tissue section margin. In these, an identifiable central duct remnant or discrete scar was 
absent, but in many such sections, the central zone was occupied by pauci-collagenous 
variable neovascularized loose fibromyxoid tissue (Figure 7). These remnants consistently 
lacked inflammation.
Tertiary lymphoid aggregates, defined as condensed aggregates of small lymphoid cells 
located at the periphery of a duct remnant (Figure 3) were distinguished from more diffuse 
mononuclear cell-rich infiltrates or inconspicuous loose aggregates and were tabulated as a 
variable independent of active or inactive status of the inflammatory infiltrate.
Alternate categories were as follows: ‘normal duct/gall bladder profile’ or ‘not assessable’ 
because of insufficient tissue or oblique orientation.
Homogeneity within a remnant was initially a suspicion based on superficial scrutiny of the 
data. An arbitrary definition of homogeneity was adopted based on three or more levels 
designated active or inactive within any B or G series. Tabulation of the data from subjects 
meeting this definition are presented in Table 3 and in a box plot, Figure 8.
Results
Using a step-section approach to sampling, with alternate remnant sections frozen and 
retained for future research, the average number of hematoxylin and eosin stained sections 
per remnant was 6.2 including both hepatic duct (B) and cystic duct/gall bladder (G) series. 
The average number of alternate levels frozen fresh and retained for research is similar.
Overall survival with the native liver 2 years post KHPE in the BA patients with followup 
data was 94/165 (58%), similar to the much larger group of patients with BA who had been 
accessioned as ChildREN network subjects during the period of observation and to the best 
results reported by other groups.
Liver tissue in the most proximal hilar sample was assessed as a guide to the depth of the 
surgical dissection during excision of the biliary remnant. Liver tissue was present in only 
30/169 subjects(18%). Total bilirubin less than 2.0 mg/dl at age 3 months post KHPE 
(p=0.84) and overall survival with the native liver at 2 years post KHPE (p=1.0) were 
unrelated to presence or absence of liver tissue in the most proximal remnant sample.
Activity and character of lesions in biliary remnant
Table 1 lists the detailed histopathological classification of all remnant levels in the B series 
and G series.
Histological features did not relate to position within the remnants in either series. This is 
dramatically demonstrated when histological diversity in the series is plotted by remnant 
level (Figure 2). Examples of the various classes of histological change encountered are 
illustrated in Figures 3–7. The range of histopathological changes was similar in the hepatic 
duct and gall bladder, the B and G series respectively. Necroinflammatory lesions (Figure 
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3a, b, c) were found in only 19/1072 levels (.02%); these occurred at all levels of remnants 
but with a minor predilection for the hilar region (hepatic duct levels 1 and 3). It is 
noteworthy that 17 of 19 examples of necroinflammatory lesions were found in remnants 
from just 4 subjects.
The stage in the proximal hepatic duct remnant was most commonly classified as active 
fibroplasia with no inflammation (Figure 4a–c) or active fibroplasia with intermixed 
mononuclear cell predominant inflammation (Figure 5a–c). Levels classified as inactive 
obliterated duct were observed at all levels of the hepatic duct and gall bladder. Well 
oriented levels with evidence suggesting a minimal paucicollagenous central scar without 
inflammation were surprisingly common (Figure 6a–c). One, or less commonly two, patent 
“main” lumens of diminished caliber were identified in 329 levels. In the latter scenario, 
both lumens were usually accompanied by a collar of active circumferential fibroplasia with 
or without a mononuclear inflammatory cell infiltrate but differing histologies were 
occasionally observed in pairs of residual ducts with inactive lesions (Figure 7a). Fibrous 
cords occasionally contained tiny residual lumens (Figure 7b). Gall bladder remnants 
displayed both active and inactive lesions and extreme variability in thickness of the smooth 
muscle component that often appeared to be independent of lesion activity. In 39 BA 
remnants, the gall bladder was histologically normal (Table 1).
Measurements of lumens were not made but estimates of lumen diameter classed as a “main 
lumen” were typically in the range of one-third to two-thirds of a normal infant extrahepatic 
bile duct (0.1 cm). Using two-tailed contingency table analysis, presence of a “main” but 
damaged duct with circumferential active fibroplasia, variable inflammation and a 
diminished main lumen (estimated at 0.3–0.5 mm) anywhere in the B series or within the 
first two most proximal levels did not predict favorable outcome, defined as early successful 
drainage or survival with native liver 2 years post KHPE.
Lumen status in the B and G-series was recorded during central review as one identifiable 
main lumen (n=329), 2 more or less equal lumens (n=24) or multiple (3 or more tiny lumens 
(n=227) or no lumen(s) identified (n=283). Multiple small ducts possibly representing 
peribiliary glands (3 or more) were most common in the B series; a single profile was most 
common in the G series (Figure 2b).
Fifty remnant levels displayed a histologically normal hepatic duct of normal diameter 
(n=11) or gall bladder (n=39) profile. In hepatic duct remnants from five subjects, we 
observed one or more levels with a duct profile of normal-size; several of these had intact 
epithelium underlain by mild subepithelial fibrosis without active inflammation. These rare 
findings were interpreted as bona fide “skip” lesions”, levels where the extrahepatic biliary 
tree was spared or the process of biliary atresia may have been arrested at a stage when the 
lumen/epithelium was not fully compromised. The majority of the histologically normal gall 
bladder sections were concentrated in a small number of subjects (n=7) in whom all samples 
of the gall bladder, though of small diameter, lacked evidence of an active or inactive atresia 
process.
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For the largest duct profile in every sample, we estimated the amount of preserved attached 
epithelium as < 10%, 10–50% or > 50% of the lumenal surface (Figure 2c). Reactive/
atrophic epithelium was most common in the hepatic duct series and normal columnar 
epithelium was most common in the cystic duct/gall bladder series. A contingency table 
analysis compared outcome in subjects with a main lumen lined by > 50% intact epithelium 
at the two most proximal levels and also at the most proximal single level of the hepatic duct 
to duct remnants in those same locations with less than 10% preserved epithelium. No 
significant difference in outcome was observed.
Inflammatory infitrates in necroinflammatory lesions were often neutrophil-rich, and 
occasionally lymphocyte-rich. In lesions classed as active fibroplasia with mixed 
inflammation, mononuclear cells always predominated (Figure 2d). Tertiary lymphoid 
aggregates (TLA) located eccentric to a damaged, active or inactive fibrotic duct remnant 
were identified somewhere in the remnant in 162 of 1063 levels from 43 subjects (Figure 
2e). In 125 remnants, no TLA were observed at any level. Fourteen subjects had 1, 10 had 2 
and 19 had 3 or more TLA.
In the hepatic duct remnant only, 63 subjects had no TLA, forty-four subjects had one TLA, 
and 57 subjects had two or more TLA. There was no significant relationship between either 
absence or presence of any lymphoid aggregates anywhere in the remnant, or when 
evaluated only for the hilar-most samples, to age at KHPE (Table 2) or to either of the two 
outcome measures. Lymphoid aggregates occurred in subjects with remnants that were 
homogeneously either active or inactive but differences in age at KHPE or outcome between 
these subgroups were not statistically significant.
Bundles of smooth muscle were found in 738 sections and were absent in 334 sections of 
remnants. Inconspicuous, partly circumferential bundles were identified in 29% of sections 
of the hepatic duct remnant (B series) and 53 % of sections of the gall bladder remnant (G 
series). Circumferential completeness and muscle quality and quantity in the gallbladder 
were not assessed.
A single microscopic nodule of cartilage was identified in non-inflamed stroma adjacent to 
one level of one gall bladder remnant.
Histological homogeneity, defined as active or inactive at all levels in remnant from a given 
subject was a common feature in the B series (n=89 or 53% of 168 subjects), and less 
common in the G series (n=65 or 38% of subjects). Remnant homogeneity throughout both 
B and G series was less common (n=36 or 21% of subjects).
Remnants from subjects with histological homogeneity in either the B or the G series are 
illustrated in a box plot that conveys the number of levels so classified in each of these 
remnants (Figure 8).
The age at the time of KHPE in those subjects with histological homogeneous hepatic duct 
remnants appear in Table 3. To investigate a possible relationship between age at KHPE and 
homogeneously active or inactive hepatic duct profiles we used contingency table analysis 
(Fisher exact test, 2-tailed) to compare the activity or lack thereof in remnants from subjects 
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< 40 days old with those 41–151 days old (p=0.0198). No statistically significant differences 
were observed between the three older cohorts. This data suggests that inactive end-stage 
histology was relatively more common in the youngest cohort and progressive active 
fibroplasia was more common by far and to an equal degree in the three older cohorts. 
However, neither active nor inactive homogeneous subsets of the hepatic duct remnant at 
KHPE predicted outcome defined either as normalization of total bilirubin at 3 months post 
KHPE or as survival with the native liver 2 years post KHPE. It is notable that almost all of 
the B-1 levels that are represented as black boxes in the box plot occurred in remnants that 
were deemed homogeneously inactive; these most proximal B levels had been classified as 
not assessable or indeterminate, as might be expected if the remnant was indeed 
homogeneously inactive.
Visceral heterotaxy
Visceral heterotaxy was defined at laparotomy and judged by the surgeon to be present in 8 
subjects who had asplenia/polysplenia, situs inversus, and/or a combination of malrotation, 
midline liver and preduodenal portal vein. Four additional subjects had malrotation only. The 
mean age of these 12 subjects at KHPE was 59 days (range 26–106 days). These remnants 
had an average of 6 levels examined which were classified as active (n=38), inactive(n=32), 
inactive with minimal scar (n=2), normal (n=1), and non-assessable (n=1). Four of 12 
remnants were homogeneous: 3 with active fibroplasia and 1 with necroinflammatory 
lesions at multiple levels. The overall pattern of homogeneous versus heterogeneous 
histology did not differ from that observed in remnants from subjects without visceral 
anomalies.
Discussion
The success of the KHPE over the last 4 decades has provided opportunity to examine the 
remnants of the biliary tree in infants with biliary atresia within the first few months of life. 
Compared to previous studies, our prospective multi-institutional study of 172 centrally 
reviewed step-sectioned biliary remnants provides important insights into the histopathology 
of BA as it exists at the time of KHPE, but raises as many questions as it resolves.
We have confirmed previous histological studies that emphasized histological heterogeneity 
(4, 7, 8). We demonstrate that necroinflammatory lesions are rare (19/ 1072 = .02%) and are 
not related to young age at KHPE, nor do they increase or decrease in frequency with age at 
KHPE; most examples were present at multiple levels in a small subgroup of patients, 
including one with malrotation. These findings cast serious doubt on the proposition that 
biliary atresia is initiated by a flagrant acute destructive process. Florid inflammatory 
cholangitis was so uncommon that it is unlikely to play a primary role in pathogenesis of BA 
unless very rapid progression to fibrosis occurs in most patients by the time remnants are 
excised. Moreover, finding such lesions at multiple levels of the hepatic duct in only a few 
subjects is more consistent with the hypothesis that these overtly destructive inflammatory 
lesions are secondary either to acquired infection or to bile-induced chemical irritation. We 
favor use of the umbrella term fibrous obliteration to describe the lesion of BA until the 
initial events that lead to BA are unraveled.
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Composition of reactive tissue in proximal hepatic duct remnant
The most prevalent lesion at any age is active fibroplasia with or without an 
accompaniment of mononuclear inflammatory cells. Active cellular circumferential 
fibroplasia, was common at the liver hilum, where it was observed in 60% of the two most 
proximal remnant sections. Homogeneous active fibroplasia throughout the remnant was 
common in all age groups except subjects 40 days old or less (n=30) who had a significantly 
higher ratio of end stage lesions to active fibroplasia than the older cohorts. Because only 11 
samples were from infants 30 days old or less at the time of KHPE, many more evaluations 
are needed from the youngest infants to verify this. The number of remnants from infants 
with visceral anomalies including heterotaxy was also small (n=12) but it is notable that 
patterns of active vs inactive histology did not differ from those with no associated visceral 
anomalies. More samples are needed in this subgroup to confirm the apparent lack of 
relationship of remnant histology to anomaly status.
Our findings have implications for any discussion regarding the time of onset of the BA 
process, and the rate of progression to complete histological obstruction. The histology at 
the earliest stages of BA is unknown but clinical evidence of elevated conjugated bilirubin in 
the earliest post-natal blood sample (15, 16), suggests frequent onset at or before birth. 
KHPE for BA in infants 30 days old is uncommon, probably less than 10% of all cases to 
date (14). Remnants from these very young infants are not well characterized as yet. 
However, we found that homogeneous inactive end-stage atresia in the remnant is more 
likely in the youngest than in the older cohorts at the time of KHPE. This suggests the 
possible existence of two populations in BA differing in the time of onset and/or in the rate 
of progression to complete obstruction, both of which are important variables that are not 
understood.
Substantial level to level variability was observed in both the hepatic duct and gall bladder in 
about 20% of the samples. Equally common in heterogeneous hepatic duct remnants were 
active lesions that consisted of partly epithelial-lined ducts or clusters of periductal glands 
accompanied by active fibroplasia with or without an associated inflammatory infiltrate, and 
inactive lesions consisting of an irregular ill-defined scar, a discrete fibrous cord, or a mere 
hint of a central pauci-collagenous scar in an otherwise well-oriented section lacking a more 
obvious remnant. In remnants with heterogeneous histology, it may be inferred that lumenal 
compromise often advances unpredictably or may even spontaneously arrest. This would 
help explain why successful drainage may be achieved even when KHPE is performed in 
infants who are 3–4 months old (20–22).
Based upon overall prevalence and the plausible presumption of evolution from fibroplasia 
to end stage obliteration, active circumferential fibroplasia is the most likely determinant of 
the fate of the biliary tree. The active-appearing fibroblasts in BA remnants react as 
myofibroblasts with antibodies to smooth muscle actin and also have been referred to as 
“juvenile” type compared to “mature” fibroblasts (8, 22, 23). Active fibroplasia is commonly 
accompanied by a variable infiltrate of mononuclear cells that defines a large subset. Future 
studies using immunomarkers to characterize the infiltrate would be important because 
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fibroplasia may be driven by cytokines produced by the infiltrate, however inconspicuous it 
might be.
In the hepatic duct series, partial obliquity of the samples undoubtedly contributed to 
reviewers’ difficulty in distinguishing residual main channel from peribiliary glands (see 
Figures 5B and 7B). A higher proportion of normal profiles was observed in the gall bladder 
compared to the hepatic duct. In 7 subjects, all sections of the gall bladder, though smaller 
than normal, were judged to be histologically normal and unaffected by the atresia process.
Smooth muscle is well developed in a normal infant gall bladder but inconstant and scant 
around the hepatic duct. Our topographic assessment of smooth muscle in the entire remnant 
disclosed that small clusters of smooth muscle fibers occur within the zones of active 
fibroplasia. Whether these are reactive or pre-existing is unclear. We speculate that a 
substantial number of the gall bladders in BA may be deficient in smooth muscle to a degree 
that may be independent of obliterating histology. Possibly disuse of the GB due to proximal 
obstruction is a factor. If it can be substantiated by further study that reduced smooth muscle 
in BA gall bladders is developmental rather than destructive, the possibility of a defect in 
mesenchymal differentiation merits consideration. One remnant had a nodule of ectopic 
cartilage adjacent to the gall bladder, a finding previously reported in BA remnants near the 
liver hilum (24, 25) and possibly a manifestation of mesenchymal instability in BA. The 
frequency of this finding in normal infants is unknown.
The reason why KHPE is a successful palliative procedure for BA has never been 
established. Normal or minimally involved duct remnants with patent lumens are often 
postulated to be the basis for successful drainage, but in practice have not consistently 
predicted success. Uncommonly we observed one or two residual sizeable lumens 
surrounded by active fibroplasia confined to one or two contiguous levels. Rarely a normal 
or near-normal hepatic duct profile was located near the hepatic hilum. Outcomes when 
these two types of residual lumens were located at the most proximal levels of the hepatic 
duct remnant did not differ significantly from the outcomes for the entire set. Thus, no 
particular histology of the hepatic duct remnant near the plane of surgical resection at the 
hilum predicted outcome. We hypothesize that establishment of bile flow after KHPE may 
be more dependent upon the ability to re-epithelialize the damaged channel at the point of 
transection then on its existence. Regrettably there was no consistency to the depth of hilar 
resection in this study; only a small fraction of the hilar samples contained liver tissue 
permitting only a tentative judgement about the status of the most proximal hepatic duct. 
Epithelialization, in turn may depend on presence of functional peribiliary glands (26). 
Multiplicity of tiny epithelialized lumina is the term we used as a proxy for peribiliary 
glands that were typically concentrated near the hepatic hilum where the Kasai incision is 
made. Whether or not affected by active fibroplasia, these structures may be capable of 
restoring a functional bile duct.
Hepatic duct regression without conventional scar
101 well-oriented levels in the sequence had no duct remnant or clearly defined scar and no 
inflammation. In many such samples, subtle evidence for regression of a pre-existing duct 
segment consisted of centrally located loose myxoid fibrovascular tissue with scant collagen 
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deposition and normal peribiliary nerves and vessels located undisturbed at the periphery of 
the sample. We propose that this observation defines a previously unrecognized lesion in BA 
remnants that highlights the variability in fibrous scar production and provides a plausable 
explanation of surgical observations of “aplasia” or absence of an observable remnant/cord 
in any part of the extrahepatic biliary tree including the common bile duct.
Tertiary lymphoid aggregates (TLA) are a form of reactive extranodal lymphoid tissue 
that may be a response to bacteria, viruses, self-antigens or cancer-related neoantigens. In 
experimental settings, TLA appear approximately 14 days after exposure to bacteria (27). 
Experimental studies have failed to identify CMV in TLA during active CMV infection 
suggesting that TLA are cytokine driven (28). TLA were present in 16% of 1072 levels 
examined with statistically significant predilection for the B series over the G series. With 
time, TLA may develop reactive centers, although none were observed in our samples.
TLA were independent of whether the entire remnant was homogeneously active or inactive. 
Thus, it may be concluded that aggregates, once formed tend to persist as biliary atresia 
evolves to complete fibrous obliteration. We observed no significant relationship of either 
absence or presence of 1, 2 or 3 or more lymphoid aggregates to age at KHPE (Table 2) or to 
the two outcome measures. This contrasts with our previous observation that presence of 
lymphoid follicles with reactive centers in hilar lymph nodes strongly associates with poor 
outcome defined as failure of the native liver to survive 2 years after KHPE (29).
If one assumes progression from initiation to active fibroplasia with or without mixed 
inflammatory cell infiltrate to end stage fibrosis, our findings indicate that the process of 
atresia, regardless of when it begins, evolves at a highly variable rate through phases of 
incomplete to complete obstruction. If so, further reducing the age of diagnosis and KHPE 
may have little or no effect on survival. On the other hand, interrupting the sequence to 
obliteration might be achieved by inhibiting fibroplasia at any time that restorable lumens 
remain.
We have documented intra-remnant variability in greater detail than in any previous reported 
study. This variability tends to obscure the relentlessly progressive histology of the process 
best appreciated in the absence of variability in the large group of remnants with 
homogeneous histology. Homogeneous remnants are synchronized in a pattern of either 
uniformly active progressive injury or inactive end stage atresia. Importantly, the youngest 
subjects with homogeneous remnants, <40 days old at KHPE have a higher proportion of 
inactive end-stage lesions than infants who are older at KHPE, but we found no relationship 
between outcome and age in the youngest cohort that included a small subgroup of 11 
subjects who were < 30 days old at KHPE.
Contemporary reviews of BA postulate the existence of an embryonic form of biliary atresia 
based on very early conjugated hyperbilirubinemia and circumstantial evidence such as 
association with congenital anomalies not limited to visceral heterotaxy, a possible 
relationship to congenital cytomegalovirus infection and a morphologically distinct variant, 
cystic biliary atresia, that may be recognized by ultrasound in utero (30–32). Compared to 
sporadic BA, cystic BA has distinctive laminar sclerosis with extensive epithelial loss (24). 
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Remnants from infants that meet the suggested criteria for embryonic BA have not been 
systematically evaluated and compared to those from infants with sporadic BA. In our small 
cohort of subjects with visceral heterotaxy we observed a pattern of active and inactive 
obliterative lesions similar to that seen in our larger group of subjects with sporadic BA and 
not differing from histology recently reported in remnants proximal to the cyst of cystic 
biliary atresia (24). In sporadic BA and especially in cystic BA, the importance of active 
fibroplasia at any point in the biliary tree to outcome is underscored by the florid 
myofibroplasia with total loss of surface epithelium that characterizes cysts (24). Thus, the 
evidence to date suggests that the morphology of atresia at the time of excision does not 
differ in the putative embryonic and sporadic forms. We interpret this to mean that histology 
in biliary remnants is not linked either to the time in early gestation when developmental 
anomalies are established or to the time in late gestation when cystic BA may be discovered 
by ultrasound. However, the tendency for homogeneous remnants from the youngest infants 
to have more inactive lesions would be consistent with existence of two forms of BA with 
either early (perinatal) or later onset, or possibly a variable rate of progression in BA that is 
independent of age.
We conclude from our detailed study of 172 remnants that extrahepatic BA is driven by 
active fibroplasia leading to fibrous or fibromyxoid lumen obliteration. Prevalence of 
partially preserved epithelium in active fibroplastic BA lesions at all ages suggests that 
epithelial regression or injury may not be a primary event or that re-epithelialization is 
already underway at the time of KHPE. We hypothesize that outcome after KHPE is the 
result of competition between active fibroplasia and re-epithelialization of retained, 
collapsed but not obliterated lumens
Associated mononuclear cell inflammatory infiltrate is inconstant and disproportionately 
minor compared to active fibroplasia. This study did not assess the nature of and potential 
fibrogenic role for mononuclear inflammatory cells that commonly lurk in the background in 
small numbers. Accordingly, in the future, either inflammation itself, or active fibroplasia 
may be suitable targets for early intervention. Antifibrotic agents such as those now in trials 
in adults with pulmonary fibrosis (32) may have a therapeutic role if safety in infants is 
established and if and when it is determined that early diagnosis with early KHPE (<30 
days) does not improve outcomes.
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Figure 1. 
This schematic demonstrates how the biliary remnants in this study were sampled for FFPE 
with alternate slices frozen for research. The average number of paraffin blocks per case was 
6. Additional levels in the B and G series were labelled by expanding the sequences in the 
schematic as needed*.
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Figure 2. 
Topographic bar graphs demonstrating distribution in remnants of histopathologic subsets 
(a), lumen status (b), residual epithelium character (c), inflammatory status (d), tertiary 
lymphoid aggregates (e), and smooth muscle (f).
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Figure 3. 
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Necroinflammatory lesions in BA remnants: All panels show remnant levels B-1 (hilum). A 
and B: Single lumens with necrotic epithelium are accompanied by intense inflammation, 
granulation tissue and tertiary lymphoid aggregates (arrows). C. Variably necrotic and 
retained injured epithelium is accompanied by stromal edema, loose fibroblast proliferation 
with focal smooth muscle differentiation, minor collagen deposition, reactive epithelium and 
a mixed mononuclear cell-neutrophil infiltrate.
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Figure 4. 
Active fibroplasia in BA remnants: A, remnant level B-1(hilum) shows active fibroplasia 
without inflammation related to duct remnants and peribiliary glands with intact epithelium 
(insert). A non-reactive hilar lymph node at lower right lacked germinal centers. B, remnant 
level B-1 shows reactive epithelium with focal subepithelial fluid (arrow). C, remnant level 
B-5 shows two lumen residues, possibly located near junction of cystic and hepatic ducts, 
with asynchronous incomplete fibrous obliteration. The larger lumen on the left is 
accompanied by prominent peribiliary glands.
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Figure 5. 
Active fibroplasia classified as mixed with mononuclear cell inflammation. A, remnant level 
B-1 shows two larger lumens, probably obliquely sectioned surrounded by slightly 
edematous fibroblastic collars with mild mononuclear cell infiltrates of varied density. 
Peribiliary glands show mild reactive change of similar nature. B, remnant level B-1 shows 
mononuclear cells lightly infiltrating zone of circumferential reactive myofibroblasts around 
epithelial channels of variable size with uncertain distinction between main duct and 
peribiliary glands. Nuclear debris is prominent (arrow). C, remnant level B-5 shows two 
lumens, one showing circumferential reactive fibroplasia with preserved epithelium and the 
other showing mononuclear cells intermixed with reactive fibroblasts and extensive 
epithelial erosion, more typical of the necroinflammatory subset.
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Figure 6. 
Paucicollagenous obliteration, a subset of inactive remnants. A, remnant level B-3 shows 
subtle central obliterative lesion with normal vessels and nerves displaced to periphery. B, 
remnant level B-7 shows ill-defined central vascularized scar. C, remnant level B-5 shows 
ill-defined central vascularized scar. Notably absent are peribiliary glands.
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Figure 7. 
Inactive fibrous cords. A, remnant level B-5 is the seat of a non-discrete central scar without 
inflammation. Cicatricial collagen surrounds surviving peribiliary glands at the periphery, 
one of which communicates with a compressed lumen lined by tall cholangiocytes. B, 
remnant level B-1 shows discrete fibrous cord with a few retained minute epithelial nests. C, 
remnant G-1 shows a discrete fibrous cord. An inactive lymph node is adjacent.
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Figure 8. 
Color-coded box plot illustrates the number and location of levels in homogeneous 
remnants. Left, B series; right, G series. Red, necroinflammatory; Yellow, active fibroplasia; 
Green, active fibroplasia with mixed inflammation; White, Inactive; Black, indeterminate or 
non-assessable. Inclusion criteria were at least three levels in the B or G series that were 
either active or inactive. The only exception in the boxplot is one remnant that had only two 
levels classed as necroinflammatory, included here to emphasize the clustering of 
necroinflammatory lesions in 4 subjects accounted for 17 of 19 levels so classified (Table 1). 
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Twenty-two of 23 remnants shown as black boxes were in the homogeneously inactive 
hepatic duct sets.
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Table 1.
Biliary Remnants: histological classification of 1072 levels in 172 subjects
B G
Active Necroinflammatory 19 9 10
516/1072 Active fibroplasia 263 160 103
Active fibroplasia/mixed inflammation 234 182 52
Inactive Perilumenal fibrosis 88 41 47
342/1072 Fibrous cord 208 127 81
Perilumenal myxoid fibrosis 32 17 15
Paucicollagenous angiomyxoid central zone/no lumen 101 57 44
Other
178/1072 Indeterminate 9 2 7
Section not assessable 68 37 31
Normal duct profile 50 11 39
Totals 1072 643 429
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Table 2.
Biliary Remnants: Tertiary Lymphoid Aggregates vs Age at KHPE in 168 subjects
0–40d 41–60d 61–79d 80–151d
Subjects n-30 N=48 N=55 N=36 168
Lymphoid Aggregates: none n=901 levels 19 39 40 27 125
Lymphoid Aggregates: 1 n=86 3 5 4 3 14
Lymphoid Aggregates: 2 n=32 3 0 3 4 10
Lymphoid Aggregates: 3 or more n=44 8 2 5 4 19
32 46 52 38 168
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Table 3.
Biliary Remnants: 134 Subjects with Homogeneous Histology in 3 or more levels of Hepatic Duct (B-series) 
vs Age at KHPE
0–40d 41–60d 61–79 80–151
Histological class of homogeneous hepatic duct 
atresia specimens (B-series)
n-30 subjects N=48 subjects N=55 subjects N=36 subjects N=169 subjects*
Necroinflammatory. 0 2 0 0 2
Active fibroplasia. 4 13 12 10 39
Active Fibroplasia/mixed inflammation. 5 10 15 9 39
Inactive. 14 13 16 11 57
Subjects with homogeneous active or inactive 
histology
23 38 43 30 134
Subjects with heterogeneous histology 7 10 12 6 35
*Age at KHPE was not available in 3 subjects
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